SCHEMBL28024643

SCHEMBL28024643

[CH2]Cc1cc(F)ccc1O

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA3 P07451 1/20 0.44
CA6 P23280 1/20 0.44
CA5A P35218 1/20 0.44
CA9 Q16790 1/20 0.44
CA14 Q9ULX7 1/20 0.44
CA5B Q9Y2D0 1/20 0.44
OXTR P30559 1/20 0.38
AVPR1A P37288 1/20 0.38
GABRA1 P14867 1/20 0.36
GABRB2 P47870 1/20 0.36
IDO1 P14902 3/20 0.36
NPC1 O15118 1/20 0.36
MAPT P10636 3/20 0.35
MEN1 O00255 2/20 0.35
KMT2A Q03164 2/20 0.35
SLC22A1 O15245 1/20 0.35
USP2 O75604 1/20 0.35
LMNA P02545 1/20 0.35
HSP90AA1 P07900 1/20 0.35
CYP3A4 P08684 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1616373 0.81 HIF1A (0.54) CA3CA6CA5ACA9CA14
SCHEMBL1906156 0.79 KLF10 (0.50) CA3CA6CA5ACA9CA14
SCHEMBL364672 0.77 ESR1 (0.53) CA3CA6CA5ACA9CA14
SCHEMBL620853 0.77 CA3 (0.44) CA3CA6CA5ACA9CA14
SCHEMBL620852 0.77 CA3 (0.44) CA3CA6CA5ACA9CA14
SCHEMBL6912849 0.77 CA3 (0.44) CA3CA6CA5ACA9CA14
SCHEMBL30041111 0.77 CA3 (0.44) CA3CA6CA5ACA9CA14
SCHEMBL2445931 0.77 GABRA1 (0.66) CA3CA6CA5ACA9CA14
SCHEMBL146619 0.76 PSEN1 (0.43) CA3CA6CA5ACA9CA14
SCHEMBL5694354 0.76 EGFR (0.50) CA9CA14GABRA1GABRB2IDO1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117624166-A Triazole derivative and preparation method and application thereof 苏州朗睿生物医药有限公司 2024-03-01 CN disclosed
CN-104822661-A Novel 5-aminotetrahydroquinoline-2-carboxylic acids and use thereof Bayer Pharma AG 2015-08-05 CN disclosed